
Studies of inherited platelet disorders have led to major advances in our knowledge of platelet physiology, thus permitting the development of antiplatelet agents that are now widely used to treat vascular diseases. New therapeutic strategies have also resulted from a better understanding of megakaryocytopoiesis, notably including the use of thrombopoietin analogs for immune thrombocytopenias.
Blood Platelets, Humans, Blood Platelet Disorders, History, 20th Century, Platelet Aggregation Inhibitors
Blood Platelets, Humans, Blood Platelet Disorders, History, 20th Century, Platelet Aggregation Inhibitors
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
